• 6-shogaol against 3-Nitropropionic acid-induced Huntington's disease in rodents: Based on molecular docking/targeting pro-inflammatory cytokines/NF-κB-BDNF-Nrf2 pathway
• A Case of Oral-Buccal-Lingual Dyskinesia and Neuropsychiatric Symptoms After Prolonged Levetiracetam Exposure
• A novel KCND3 variant in the N-terminus impairs the ionic current of Kv4.3 and is associated with SCA19/22
• A Systematic Review of Botulinum Toxin Injection in Pediatric Dystonia
• A Term Neonate with Congenital Torticollis
• Advancing age and the rs6265 BDNF SNP are permissive to graft-induced dyskinesias in parkinsonian rats
• Age- and disease-related autophagy impairment in Huntington disease: New insights from direct neuronal reprogramming
• Analysis of Brain, Blood, and Testis Phenotypes Lacking the <em>Vps13a</em> Gene in C57BL/6N Mice
• Analysis of clinical characteristics and variant of NKX2-1 gene in a Chinese boy with Brain-Lung-Thyroid syndrome
• Apolipoproteine and <em>KLOTHO</em> Gene Variants Do Not Affect the Penetrance of Fragile X-Associated Tremor/Ataxia Syndrome
• Ataxias in Brazil
• Autoimmune Movement Disorders
• Automated analysis of spontaneous eye blinking in patients with acute facial palsy or facial synkinesis
• Canine paroxysmal dyskinesia-a review
• Carbamazepine responsive episodic dystonia and hallucination due to pyruvate dehydrogenase E2 (DLAT) gene mutation
• Cerebellar nuclei cells produce distinct pathogenic spike signatures in mouse models of ataxia, dystonia, and tremor
• Clinical and genetic variability among Bulgarian patients with autosomal recessive spastic ataxia of Charlevoix-Saguenay
• Clinical Manifestations
• Cost-Effectiveness Analysis of COMT-Inhibitors as Adjuvant Treatments to Levodopa in Patients with Advanced Parkinson's Disease
• COVID-19 vaccination and involuntary movements: A longitudinal panel study
• Current use of neurotoxins for alleviating symptoms of cervical dystonia
• CV Junction Drug-Resistant Tuberculosis Presenting as Acquired Torticollis: A Rare Case Presentation
• Daytime bruxism, tardive orofacial dyskinesia, and dysphagia as side effects to duloxetine use over nine years in an octogenarian
• Development of a Tremor Detection Algorithm for Use in an Academic Movement Disorders Center
• Dynamic undirected graphical models for time-varying clinical symptom and neuroimaging networks
• Effectiveness of pharmacological treatments for severe agitation in real-world emergency settings: protocol of individual-participant-data network meta-analysis
• Endoscopic minimally invasive treatment of congenital muscular torticollis in children
• Enhancement of Haloperidol-Induced Catalepsy by GPR143, an l-DOPA Receptor, in Striatal Cholinergic Interneurons
• Exploring functional and structural connectivity disruptions in spinocerebellar ataxia type 3: Insights from gradient analysis
• Extrapyramidal side effects with nonantipsychotic medications
• Feasibility of whole-body MRI for cancer screening in children and young people with ataxia telangiectasia: A mixed methods cross-sectional study
• Focused neurological assessment to differentiate essential tremor from functional tremor
• Gabapentin-induced Multifocal Myoclonus
• Gastrodin Improves the Activity of the Ubiquitin-Proteasome System and the Autophagy-Lysosome Pathway to Degrade Mutant Huntingtin
• Genetic mutations in Parkinson's disease: screening of a selected population from North-Eastern Italy
• Genotype-phenotype spectrum and correlation of PHARC Syndrome due to pathogenic ABHD12 variants
• Global huntingtin knockout in adult mice leads to fatal neurodegeneration that spares the pancreas
• Gluten Ataxia and mGluR1 Autoimmune Encephalitis Presenting as Acute Cerebellar Ataxia: A Case Report
• Grisel's syndrome : about two cases of a atlantoaxial (C1-C2) subluxation
• Horizontal Pendular Nystagmus and Ataxia Secondary to Severe Hypomagnesemia
• Huntingtin contains an ubiquitin-binding domain and regulates lysosomal targeting of mitochondrial and RNA-binding proteins
• Huntingtin is an RNA binding protein and participates in <em>NEAT1</em>-mediated paraspeckles
• Huntington's disease cellular phenotypes are rescued non-cell autonomously by healthy cells in mosaic telencephalic organoids
• Hyperkinesias in Leigh-like Syndrome with Complex-I Deficiency Due to m.10191T&gt;C in MT-ND3
• Identification of molecular targets and small drug candidates for Huntington's disease via bioinformatics and a network-based screening approach
• Immune profiling and functional analysis of NK and T cells in ataxia telangiectasia
• Inaugural Patient-Reported Registry of Pediatric Opsoclonus-Myoclonus-Ataxia Syndrome: Presentation, Diagnosis, and Treatment of 194 Patients
• Lessons from the ATTeST trial in ataxia telangiectasia
• Longitudinal Changes of Clinical, Imaging, and Fluid Biomarkers in Preataxic and Early Ataxic Spinocerebellar Ataxia Type 2 and 7 Carriers
• Maculopathy and adult-onset ataxia in patients with biallelic MFSD8 variants
• Metabolic Profile in Rats during Long-Term Restriction of Motor Activity
• mRNA Nuclear Clustering Leads to a Difference in Mutant Huntingtin mRNA and Protein Silencing by siRNAs <em>In Vivo</em>
• Multi-omic analysis of Huntington's disease reveals a compensatory astrocyte state
• Mutant huntingtin impairs neurodevelopment in human brain organoids through CHCHD2-mediated neurometabolic failure
• Mycotoxin intoxication in 54 dogs after ingestion of walnuts
• Neural Basis of Agitated Behaviors in Patients with Amnestic Mild Cognitive Impairment and Alzheimer's Disease
• Neurodevelopmental impact of a mutation in the RHOBTB2 gene
• Neuroprotection by ADAM10 inhibition requires TrkB signaling in the Huntington's disease hippocampus
• Nilotinib treatment outcomes in autosomal dominant spinocerebellar ataxia over one year
• Nuclear poly-glutamine aggregates rupture the nuclear envelope and hinder its repair
• Opposite regulation by L-DOPA receptor GPR143 of the long and short forms of the dopamine D2 receptors
• Opsoclonus-Ataxia Syndrome in a Patient With Small-Cell Lung Cancer Treated With Immune Checkpoint Inhibitors
• Opsoclonus-myoclonus-ataxia syndrome associated with bacterial urinary tract infection
• Oxidative stress and the multifaceted roles of ATM in maintaining cellular redox homeostasis
• Parkinson's disease and levodopa-induced dyskinesias: a quantitative analysis through (99m)Tc-TRODAT-1 SPECT imaging of the brain
• Parkinson's disease is not just a tremor
• Parkinsonian Tremor as Unstable Feedback in a Physiologically Consistent Control Framework
• Paroxysmal movement disorders
• Peripheral sequestration of huntingtin delays neuronal death and depends on N-terminal ubiquitination
• Person-centred integrated care for people living with Parkinson's, Huntington's and Multiple Sclerosis: A systematic review
• Polyminimyoclonus in Hirayama Disease
• Preimplantation Genetic Testing of Spinocerebellar Ataxia Type 3/Machado-Joseph Disease-Robust Tools for Direct and Indirect Detection of the <em>ATXN3</em> (CAG)_n Repeat Expansion
• Protocol for a randomised controlled unblinded feasibility trial of HD-DRUM: a rhythmic movement training application for cognitive and motor symptoms in people with Huntington's disease
• Pseudo-Orthostatic Tremor in Graves' Disease: A Possible Early Sign of Parkinsonism?
• Reliability and concurrent validity of the Active Movement Scale (AMS) in adults with musculoskeletal disorders
• Rescue Lead Implantation After Deep Brain Stimulation for Parkinson's Disease: A Single-Center Experience and Case Series
• Role of Botulinum Toxin in Treatment of Secondary Dystonia: A Case Series and Overview of Literature
• Saccades, pupil response and blink abnormalities in Huntington's disease patients during free viewing
• Safety and efficacy of intra-erythrocyte dexamethasone sodium phosphate in children with ataxia telangiectasia (ATTeST): a multicentre, randomised, double-blind, placebo-controlled phase 3 trial
• Sensory-motor circuit is a therapeutic target for <em>dystonia musculorum</em> mice, a model of hereditary sensory and autonomic neuropathy 6
• Severe choreiform movement disorder following COVID-19
• Specific Biomarkers in Spinocerebellar Ataxia Type 3: A Systematic Review of Their Potential Uses in Disease Staging and Treatment Assessment
• Stiff Person Syndrome and GAD Antibody-Spectrum Disorders
• Successful Synergistic Use of Gabapentin With Other Antiepileptic Drugs in the Management of Lance-Adams Syndrome Complicated by Alcohol Withdrawal Seizures: A Case Report
• Sydenham's Chorea in Children with Acute Rheumatic Fever: An Echocardiographic Survey of Pediatric Patients in Northwestern Iran
• Symptom progression in neuromyelitis optica spectrum disorder from ataxia through syncope to neuropathic pain: A case report
• Symptomatic Palatal Tremors in a Rare Treatable Neurometabolic Disorder: A Case Report
• The episodic ataxias
• The New Face of Dynamic Mutation-The CAA [CAG]n CAA CAG Motif as a Mutable Unit in the <em>TBP</em> Gene Causative for Spino-Cerebellar Ataxia Type 17
• The parkin V380L variant is a genetic modifier of Machado-Joseph disease with impact on mitophagy
• Toll-like receptor 4 deficiency in Purkinje neurons drives cerebellar ataxia by impairing the BK channel-mediated after-hyperpolarization and cytosolic calcium homeostasis
• Transcranial direct current stimulation improves tardive dyskinesia in long-term hospitalized patients with chronic schizophrenia
• Tremor Estimation and Removal in Robot-Assisted Surgery Using Improved Enhanced Band-Limited Multiple Fourier Linear Combiner
• Trial to assess the tolerability of using felodipine to upregulate autophagy as a treatment of Huntington's disease (FELL-HD): a phase II, single-centre, open-label, dose-finding trial protocol
• Two Pediatric Cases of Primary Ciliary Dyskinesia Caused by Loss-of-Function Variants in Oral-Facial-Digital Syndrome Gene, OFD1
• Two-step Ultrasound Guidance for Needle Electromyography and Botulinum Toxin Injections in Cervical Dystonia
• Tyrosinase inhibition prevents non-coplanar polychlorinated biphenyls and polybrominated diphenyl ethers-induced hyperactivity in developing zebrafish: Interaction between pigmentation and neurobehavior
• Unraveling the Molecular Complexity of N-Terminus Huntingtin Oligomers: Insights into Polymorphic Structures
• White Matter Microstructural Changes Using Ultra-Strong Diffusion Gradient MRI in Adult-Onset Idiopathic Focal Cervical Dystonia
• Whole genome joint analysis reveals ATM:C.1564_1565del variant segregating with Ataxia-Telangiectasia and breast cancer